Jane F Barlow
CIK 1736026 · last filed 2026-07-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$95.7K
Companies
5
Total Filings
18
Lifetime Open-Market Net
$10.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SERA | Director | 47,088 | $2.03 | $95.6K | $0 | 5 | 2026-07-14 |
| Viracta Therapeutics, Inc. (VIRX) Delisted | Director | — | $0.01 | — | $0 | 4 | 2024-06-24 |
| CONTRAFECT Corp (CFRX) Delisted | Director | — | $0.05 | — | $0 | 2 | 2022-05-18 |
| MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Director | — | — | — | $0 | 3 | 2020-10-01 |
| TXMD | Director | 63 | $2.06 | $130 | $10.0K | 4 | 2019-08-14 |
Recent Filings · Page 2 of 2
18 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-11 | CONTRAFECT Corp (CFRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-10-01 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Disp (D) | — | $0 | EDGAR |
| 2020-06-24 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-13 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-08-14 | TXMD | Buy (P) | +3,144 | $10.0K | EDGAR |
| 2019-06-24 | TXMD | Grant (A) | — | $0 | EDGAR |
| 2018-07-05 | TXMD | Grant (A) | — | $0 | EDGAR |
| 2018-04-18 | TXMD | Grant (A) | — | $0 | EDGAR |
Showing 11–18 of 18
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.